Katana Thrombectomy System
Pulmonary Embolism (PE)
Key Facts
About Akura Medical
Akura Medical is a clinical-stage medical device company targeting the large and underserved venous thromboembolism (VTE) market, specifically pulmonary embolism (PE). Its core technology is the Katana Thrombectomy System, which combines an intelligent catheter, HydroBlade jet technology, and a Sentinel console for real-time procedural insights to address limitations of existing treatments. Backed by Shifamed's innovation hub and having recently closed a $53M Series C round, the company is actively enrolling patients in a U.S. pivotal trial for PE, positioning it for potential future commercialization. Akura operates as a private, pre-revenue entity advancing a single, integrated platform through clinical development.
View full company profileTherapeutic Areas
Other Pulmonary Embolism (PE) Drugs
| Drug | Company | Phase |
|---|---|---|
| Platform Extension | Retriever Medical | Pre-clinical/Concept |
| FlowTriever System | Inari Medical | Commercial / PMA Supplement |